First-in-human evaluation of a novel subcutaneous intraosseous vascular access device for outpatient infusions

Abstract

This novel, fully subcutaneous IO device appears to be a feasible, usable, and safe option for short-term infusion therapy in patients with CKD or challenging venous access. These findings support further investigation into its use as a long-term intraosseous vascular access option.